Awards

2024 NP/PA Award Recipients

Amy Donegan, CPNP-PC
Nationwide Children’s Hospital

Helena in’t Veld, NP
Arizona Centers for Digestive Health

Taylor Knight, RN, MSN, CRNP-PC
Children’s of Alabama

Yulia Lyuboslavsky, ACNS-BC
Austin Gastroenterology/GI Alliance

Quaadir Otto-Smallwood, PA-C
Penn State Health

2024 Young Investigators Abstract Award Recipients

Ju-Hyun Ahn, University of North Carolina at Chapel Hill

ZINC RESTRICTION BY INTESTINAL E. COLI – PRODUCED YERSINIABACTIN ACTIVATES HIF-1α IN MACROPHAGES TO PROMOTE CD-ASSOCIATED FIBROSIS.

Nicole Anderson, Purdue University

A NOVEL MOUSE MODEL OF CROHN’S DISEASE DRIVEN BY THE INTERACTION OF CD4 T CELLS AND GUT MICROBIOTA-RESPONSIVE γδ T CELLS

Bin Bao, Boston Children’s Hospital, Harvard Medical School

BACTERIAL SPHINGOLIPIDS EXACERBATE COLITIS BY INHIBITING ILC3-DERIVED IL-22 PRODUCTION

Siyan Cao, Washington University in St. Louis School of Medicine

GROUP 3 INNATE LYMPHOID CELLS RELY ON ER STRESS RESPONSE FOR CYTOKINE PRODUCTION IN IBD

Brad Constant, Children’s Hospital Colorado

INSURER-MANDATED MEDICATION UTILIZATION BARRIERS ARE ASSOCIATED WITH DECREASED INSURANCE SATISFACTION AND ADVERSE CLINICAL OUTCOMES: AN IBD PARTNERS SURVEY

Stefania De Santis, Case Western Reserve University

UPREGULATION OF SERPINE1/PAI-1 INDUCED BY IL-33 CONTRIBUTES TO INTESTINAL FIBROSIS IN A CROHN’S DISEASE-LIKE ILEITIS MODEL

Lawrence Kogan, Yale New Haven Hospital

CHRONOLOGICAL AGE INFLUENCES TREATMENT DECISION IN INFLAMMATORY BOWEL DISEASE: AN IBD QORUS COLLABORATIVE STUDY

Marco Losa, Boston Children’s Hospital, Harvard Medical School

BIOACTIVE INTERLEUKIN-1 DETECTED IN IBD PATIENT INTESTINAL BIOPSIES IS A HALLMARK OF ULCERS AND CORRELATES WITH TRANSCRIPTOMIC ASSESSMENTS, INCLUDING AN ULCER-ASSOCIATED GENE MODULE

Natalia Plott, Riley Hospital for Children at Indiana University Health

IMPROVEMENT IN GROWTH AND NUTRITION STATUS AFTER ANTI-TNF THERAPY INITIATION AMONG PATIENTS WITH PEDIATRIC CROHN’S DISEASE: RESULTS FROM THE COMBINE TRIAL

Piu Saha, University of Toledo College of Medicine and Life Sciences

STERILE NEUTROPHILIA INDUCED VIA CXCR4 ANTAGONISM MITIGATES COLONIC INFLAMMATION BY ENHANCING IMMUNOSUPPRESSIVE REGULATORY T CELLS IN MICE

Application Information

The Crohn’s & Colitis Congress will award complementary registration to the 2022 meeting to up to ten young investigators and five nurses and advanced practice providers. Applications will be accepted from 9 a.m. EDT on Wednesday, Sept. 8 through 9 p.m. EDT on Wednesday, Oct. 20, 2022. 

Applicants are:

  • Early career investigators currently in training or within five years of completing their training.
  • Listed as the presenting author of an abstract accepted for oral or poster presentation at the 2021 Crohn’s & Colitis Congress..

Recipients will receive complementary registration to the 2021 meeting.

The deadline for young investigators and nurses to submit an application for complementary registration to the 2022 meeting has passed. 

Notifications will be sent to all applicants in early December. 

Young Investigators Abstract Awards

  • Congress administration will award up to ten young investigators complementary registration for the 2024 Congress.
  • Applicants for the award must be an early career investigator currently in training or within five years of completing their training; additionally, applicants must be listed as the presenting author of an abstract accepted for presentation at the 2024 Crohn’s & Colitis Congress.
  • To apply, complete and submit all three award questions as part of an abstract submission by 9 p.m. EDT on Wednesday, Oct. 18, 2023.
  • Applicants will be asked to briefly describe their career stage and how Congress attendance will benefit their career in 4000 or fewer characters.
  • Applicants are not required to be the submitting author of the abstract; instead, submitting authors may complete the application fields on behalf of the applicant provided that the applicant composes the personal statement.
  • Prior award recipients are not eligible to receive a 2024 award.
  • Award notifications will be emailed to applicants in December 2023.

Applicants for the Young Investigators Abstract Award must be:

  • Early career investigators currently in training or within five years of completing their training.
  • Listed as the presenting author of an abstract accepted for oral or poster presentation at the 2022 Crohn’s & Colitis Congress.

Applications may be submitted at the abstract submission site. To apply for the award, complete the “Awards” fields when submitting an abstract. Applicants are asked to verify their eligibility and also provide a brief (4000 characters maximum) personal statement.

Applicants are not required to be the submitting author of the abstract; instead, submitting authors may complete the application fields on behalf of the applicant provided that the applicant composes the personal statement.

Applications are due at the abstract submission site by 9 p.m. EDT on Wednesday, Oct. 20, 2021. Previous recipients of the award are not eligible to apply.

Contact Congress administration with any questions about applying.

Nurses/Advanced Practice Providers Award

  • The Crohn’s & Colitis Congress will award up to five nurses or advanced practice providers complimentary registration to the 2023 Crohn’s & Colitis Congress.
  • Applicants for the Nurses/Advanced Practice Providers Award must be a registered nurse, clinical nurse specialist, nurse practitioner, or physician assistant in any practice setting currently involved in IBD patient management. Graduate students in any of the listed fields with an identified interest in the IBD patient population will also be considered.
  • Applications for the Nurses/Advanced Practice Providers Award will be accepted online through 12 p.m. (noon) EDT on Friday, Oct. 21, 2022.
  • To apply for the award, applicants must submit the following materials:
    • Current curriculum vitae.
    • Estimate of the average number of IBD patients seen weekly in your practice setting.
    • A brief (500 words or fewer) statement as to why attending the Crohn’s & Colitis Congress is important to you and the patients you manage. Please state the significance your participation in this conference will have on your practice, patient care or knowledge of IBD. Include how you will share your experience with others (if applicable), list any questions you hope this conference will help answer, or share any ideas or projects that you hope to develop further as a result of attending this conference.
  • Previous recipients of the award are not eligible to receive a 2023 award.
  • Award notifications will be sent by email in December 2022.

Nurses and advanced practice providers may apply for complementary registration to the 2022 Crohn’s & Colitis Congress.

As part of the application, applicants are asked to submit their CV and a brief (500 words or less) personal statement.

Applications must be submitted by 9 p.m. EDT on Wednesday, Oct. 20, 2021. Previous recipients of the award are not eligible to apply.

Contact Congress administration with any questions about applying.

This website uses cookies to provide you with the best experience on our website. If you wish to disable cookies, please do so in your browser settings. Your continued use of our site without disabling your cookies is subject to the cookie policy. Learn More